2025-04-12_00000110
|
ligand
|
9BBR
SARS-CoV-2 Mpro in complex with compound 6b inhibitor;
X-ray diffraction 2.15Å
Protein #1
306 residues (100% resolved)
Raw Sequence ...
SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ
Canonical Sequence ...
SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ
Non polymer #2
A1ALL
InChI=1S/C26H31FN4O3/c1-16(2)13-23(26(34)30-22(15-28)14-20-11-12-29-24(20)32)31-25(33)19-5-3-17(4-6-19)18-7-9-21(27)10-8-18/h3-10,15-16,20,22-23,28H,11-14H2,1-2H3,(H,29,32)(H,30,34)(H,31,33)/t20-,22+,23-/m0/s1
InChI=1S/C26H31FN4O3/c1-16(2)13-23(26(34)30-22(15-28)14-20-11-12-29-24(20)32)31-25(33)19-5-3-17(4-6-19)18-7-9-21(27)10-8-18/h3-10,15-16,20,22-23,28H,11-14H2,1-2H3,(H,29,32)(H,30,34)(H,31,33)/t20-,22+,23-/m0/s1
SMILES: CC(C)C[C@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3ccc(cc3)F
CC(C)C[C@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3ccc(cc3)F
Biounit #1
monomer
Download coordinates
Tube
Model
Reference
100%